feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / China Confirms Zero Nipah Virus Cases Amid India Outbreak

China Confirms Zero Nipah Virus Cases Amid India Outbreak

29 Jan

•

Summary

  • China detected no Nipah virus infections following an Indian outbreak.
  • Nipah virus has a high fatality rate of 40% to 75%.
  • Chinese researchers report a promising antiviral drug for Nipah virus.
China Confirms Zero Nipah Virus Cases Amid India Outbreak

National disease control authorities in China have confirmed no Nipah virus infections detected within the country, following a recent outbreak in India. While the risk of imported cases persists, China's National Disease Control and Prevention Administration stated that the probability of impact remains low due to geographical distance from the affected Indian state.

The Nipah virus, first identified in the 1990s, is a zoonotic pathogen with a high fatality rate, estimated between 40% and 75%. Transmission occurs through direct contact with infected animals, patients, or contaminated materials. Symptoms can range from fever and vomiting to severe respiratory and neurological issues, with no specific treatment other than supportive care.

In response, China has enhanced monitoring, strengthened border region response capabilities, and stockpiled testing kits. Concurrently, Chinese researchers have reported that a domestically developed antiviral drug, initially approved for COVID-19, shows significant promise against the Nipah virus, presenting a potential oral treatment candidate.

trending

Ohio snow emergency declared

trending

TikTok down in United States

trending

Andreeva matches Venus Williams' feat

trending

Warrington Hospital baby death

trending

Alexander Zverev advances in Australia

trending

Oilers host Capitals

trending

London celebrates Chinese New Year

trending

Liza Minnelli defends AI use

Neighboring countries like Thailand and Myanmar have also heightened health screenings and surveillance measures for travelers arriving from affected areas, amid global concerns over the Nipah virus.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
No, China has confirmed zero Nipah virus infections detected within the country.
The Nipah virus has a high fatality rate, estimated between 40% and 75%.
Currently, there are no specific remedies or vaccines available, but supportive care is provided, and Chinese researchers report a promising antiviral drug candidate.

Read more news on

Indiaside-arrowHealthside-arrowChinaside-arrowThailandside-arrow

You may also like

Deadly Nipah Virus Strikes India: Tourists Warned

2 hours ago • 2 reads

article image

Deadly Nipah Virus: What You Need to Know

14 hours ago • 4 reads

article image

Doctor's Rapid Response Halts Deadly Nipah Virus

1 day ago • 36 reads

article image

NHS Under Strain as Flu Cases Stabilize

1 Jan • 155 reads

article image

Holiday Germs Spike: Flu, Norovirus, COVID-19 Surging

22 Dec, 2025 • 225 reads

article image